Literature DB >> 33570615

TTP: the evolution of clinical practice.

James N George1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33570615     DOI： 10.1182/blood.2020009654

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Prognostic value of dynamic cardiac biomarkers in patients with acquired refractory thrombocytopenic purpura: A retrospective study in Chinese population.

Authors:  Yinan Xu; Chengyuan Gu; Ruju Wang; Jiaqian Qi; Jun Wang; Tingbo Jiang; Min Jiang; Depei Wu; Tao You; Jianhong Fu
Journal:  J Clin Lab Anal       Date:  2022-06-11       Impact factor: 3.124

Review 2.  TTP: From empiricism for an enigmatic disease to targeted molecular therapies.

Authors:  Nuno A G Graça; Bérangère S Joly; Jan Voorberg; Karen Vanhoorelbeke; Nicolas Béranger; Agnès Veyradier; Paul Coppo
Journal:  Br J Haematol       Date:  2022-02-10       Impact factor: 8.615

3.  Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019.

Authors: 
Journal:  J Thromb Haemost       Date:  2022-03-11       Impact factor: 16.036

Review 4.  The standard of care for immune thrombotic thrombocytopenic purpura today.

Authors:  X Long Zheng
Journal:  J Thromb Haemost       Date:  2021-06-30       Impact factor: 16.036
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.